The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of whole-genome sequencing in routine clinical practice.
 
Kris Samsom
No Relationships to Disclose
 
Kim Monkhorst
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Diaceutics (Inst); Lilly (Inst); MSD (Inst); Roche (Inst)
Speakers' Bureau - AstraZeneca (Inst); Benecke (Inst); MSD (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Delfi Diagnostics (Inst); Personal Genome Diagnostics (Inst)
Travel, Accommodations, Expenses - Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Luuk J. Schipper
No Relationships to Disclose
 
Paul Roepman
No Relationships to Disclose
 
Linda J.W. Bosch
Patents, Royalties, Other Intellectual Property - inventor on several CRC stool biomarker patents pending.
 
Ewart de Bruijn
No Relationships to Disclose
 
Immy Riethorst
No Relationships to Disclose
 
Lieke Schoenmaker
No Relationships to Disclose
 
Lizet Van Der Kolk
No Relationships to Disclose
 
Tineke Buffart
No Relationships to Disclose
 
Jacobus J.M. van der Hoeven
No Relationships to Disclose
 
Edwin P.J.G. Cuppen
Consulting or Advisory Role - Illumina (Inst)
 
Emile E. Voest
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Biogeneration Ventures; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); InteRNA; MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Gerrit A. Meijer
Research Funding - Exact Sciences (Inst); Hartwig Medical Foundation (Inst); Personal Genome Diagnostics (Inst); Sentinel Diagnostics (Inst); Sysmex (Inst)
Patents, Royalties, Other Intellectual Property - Several patents pending (Inst)